PRESCRIPTION GIVEN FOR CHAIN DRUG ILLS

CHICAGO -- As national health care undergoes reorganization, chain drug retailers are struggling to remain competitive. Survival will depend upon chain drug's ability to harness its inherent resources and fully integrate into the emerging health-care system, according to a J.P. Morgan analyst.The realities of what chain drug retailers face in today's marketplace were driven home by Mark Husson, vice

CHICAGO -- As national health care undergoes reorganization, chain drug retailers are struggling to remain competitive. Survival will depend upon chain drug's ability to harness its inherent resources and fully integrate into the emerging health-care system, according to a J.P. Morgan analyst.

The realities of what chain drug retailers face in today's marketplace were driven home by Mark Husson, vice president at J.P. Morgan Securities, New York, during a presentation at the Alexandri

Register to view the full article